βγ-CAT, a non-lens betagamma-crystallin and trefoil factor complex, induces calcium-dependent platelet apoptosis

Thrombosis and Haemostasis

Volumn 105, Issue 5, 2011, Pages 846-854

  Gao, Qian ^a,b   Xiang, Yang ^a,c   Chen, Zhongming ^a,c   Zeng, Lin ^a,c   Ma, Xutong ^a,c   Zhang, Yun ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

CAT, Ca2+; Non lens crystallins; Platelet apoptosis; Trefoil factor

Indexed keywords

BETA GAMMA CAT; CALCIUM; CASPASE 3; CRYSTALLIN; CYTOCHROME C; GROWTH FACTOR; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEIN BAK; PROTEIN BAX; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANIMALS; ANURA; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BETA-CRYSTALLINS; BLOOD PLATELETS; CALCIUM; CASPASE 3; CELLS, CULTURED; CYTOCHROMES C; GAMMA-CRYSTALLINS; HUMANS; INVERTEBRATE HORMONES; MITOCHONDRIAL MEMBRANES; PEPTIDES; PLATELET ACTIVATION;

EID: 79955764788     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-10-0690     Document Type: Article

References (49)

1. Munnix IC, Cosemans JM, Auger JM, et al. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102: 1149-1156.
2. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116: 205-219.
3. Schulze-Osthoff K, Walczak H, Droge W, et al. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 1994; 127: 15-20.
4. Lopez JJ, Redondo PC, Salido GM, et al. N, N, N', N'-tetrakis(2-pyridylmethyl) ethylenediamine induces apoptosis through the activation of caspases-3 and-8 in human platelets. A role for endoplasmic reticulum stress. J Thromb Haemost 2009; 7: 992-999.
5. van der Wal DE, Du VX, Lo KS, et al. Platelet apoptosis by cold-induced glycoprotein Ibalpha clustering. J Thromb Haemost 2010; 8: 2554-2562.
6. Lopez JJ, Salido GM, Pariente JA, et al. Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J Thromb Haemost 2008; 6: 1780-1788.
7. Leytin V, Allen DJ, Mykhaylov S, et al. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006; 4: 2656-2663.
8. Lin KH, Hsiao G, Shih CM, et al. Mechanisms of resveratrol-induced platelet apoptosis. Cardiovasc Res 2009; 83: 575-585.
9. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128: 1173-1186.
10. Zhang H, Nimmer PM, Tahir SK, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ 2007; 14: 943-951.
11. Augereau O, Rossignol R, DeGiorgi F, et al. Apoptotic-like mitochondrial events associated to phosphatidylserine exposure in blood platelets induced by local anaesthetics. Thromb Haemost 2004; 92: 104-113.
12. Bertino AM, Qi XQ, Li J, et al. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003; 43: 857-866.
13. Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003; 43: 526-535.
14. Gwozdz AM, Leung R, Wang H, et al. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects. Thromb Haemost 2010; 103: 1218-1227.
15. Wolf BB, Goldstein JC, Stennicke HR, et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999; 94: 1683-1692.
16. Vanags DM, Orrenius S, Aguilar-Santelises M. Alterations in Bcl-2/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis. Br J Haematol 1997; 99: 824-831.
17. Rand ML, Wang H, Bang KW, et al. Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady-state senescence. J Thromb Haemost 2004; 2: 651-659.
18. Pereira J, Soto M, Palomo I, et al. Platelet aging in vivo is associated with activation of apoptotic pathways: studies in a model of suppressed thrombopoiesis in dogs. Thromb Haemost 2002; 87: 905-909.
19. Jaenicke R, Slingsby C. Lens crystallins and their microbial homologs: structure, stability, and function. Crit Rev Biochem Mol Biol 2001; 36: 435-499.
20. Ogawa M, Takahashi TC, Takabatake T, et al. Isolation and characterization of a gene expressed mainly in the gastric epithelium, a novel member of the ep37 family that belongs to the betagamma-crystallin superfamily. Dev Growth Differ 1998; 40: 465-473.
21. Ray ME, Wistow G, Su YA, et al. AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci USA 1997; 94: 3229-3234.
22. Thim L, May FE. Structure of mammalian trefoil factors and functional insights. Cell Mol Life Sci 2005; 62: 2956-2973.
23. Hauser F, Roeben C, Hoffmann W. xP2, a new member of the P-domain peptide family of potential growth factors, is synthesized in Xenopus laevis skin. J Biol Chem 1992; 267: 14451-14455.
24. Hauser F, Hoffmann W. xP1 and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa. J Biol Chem 1991; 266: 21306-21309.
25. Zhang J, Zhang Y, Wan SG, et al. Bm-TFF2, a trefoil factor protein with platelet activation activity from frog Bombina maxima skin secretions. Biochem Biophys Res Commun 2005; 330: 1027-1033.
26. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003; 4: 721-732.
27. Liu SB, He YY, Zhang Y, et al. A novel non-lens betagamma-crystallin and trefoil factor complex from amphibian skin and its functional implications. PLoS One 2008; 3: e1770.
28. Aravind P, Mishra A, Suman SK, et al. The betagamma-crystallin superfamily contains a universal motif for binding calcium. Biochemistry 2009; 48: 12180-12190.
29. Hunter SE, Clarke IN, Kelly DC, et al. Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect Immun 1992; 60: 102-110.
30. Qian JQ, Liu SB, He YY, et al. Acute toxicity of betagamma-CAT, a naturally existing non-lens betagamma-crystallin and trefoil factor complex from frog Bombina maxima skin secretions. Toxicon 2008; 52: 22-31.
31. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907.
32. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 663-666.
33. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-519.
34. Muhlestein JB. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost 2010; 103: 71-82.
35. Bergmeier W, Schulte V, Brockhoff G, et al. Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry 2002; 48: 80-86.
36. Redondo PC, Salido GM, Pariente JA, et al. Dual effect of hydrogen peroxide on store-mediated calcium entry in human platelets. Biochem Pharmacol 2004; 67: 1065-1076.
37. Bevins CL, Zasloff M. Peptides from frog skin. Annu Rev Biochem 1990; 59: 395-414.
38. Clarke BT. The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biol Rev Camb Philos Soc 1997; 72: 365-379.
39. Zhang Y, Yu G, Xiang Y, et al. Bm-TFF2, a toad trefoil factor, promotes cell migration, survival and wound healing. Biochem Biophys Res Commun 2010; 398: 559-564.
40. He YY, Liu SB, Lee WH, et al. Melanoma cell growth inhibition by betagamma-CAT, which is a novel non-lens betagamma-crystallin and trefoil factor complex from frog Bombina maxima skin. Toxicon 2008; 52: 341-347.
41. Tan KT, Lip GY. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost 2005; 94: 488-492.
42. Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999; 93: 4222-4231.
43. Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med 2010; 89: 109-121.
44. Leytin V, Allen D, Mutlu A, et al. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. British journal of haematology 2008; 142: 494-497.
45. Leytin V, Allen DJ, Lyubimov E, et al. Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation. Br J Haematol 2007; 136: 762-764.
46. Wang Z, Li S, Shi Q, et al. Calmodulin antagonists induce platelet apoptosis. Thromb Res 2010; 125: 340-350.
47. Heon Seo K, Ko HM, Kim HA, et al. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factorkappaB activation. Cancer Res 2006; 66: 4681-4686.
48. Schubert P, Devine DV. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010; 99: 112-122.
49. Rizzuto R, Pinton P, Ferrari D, et al. Calcium and apoptosis: facts and hypotheses. Oncogene 2003; 22: 8619-8627.